Stocks · Korea
464280
KOSDAQ
Tdspharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+2.00%
1M-3.78%
3M-10.69%
6M-34.81%
1Y-45.15%
YTD-43.38%
52W high10,800원
52W low4,240원
From 52W high-48.15%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2024 | 275억 | 37억 | 37억 | 13.6% |
| 2025 | 276억 | 38억 | 43억 | 13.6% |
| Quarterly | ||||
| 2024 3Q | 65억 | 8억 | 8억 | 13.1% |
| 2025 1Q | 53억 | 2억 | 4억 | 3.6% |
| 2025 2Q | 56억 | 3억 | 9억 | 5.8% |
| 2025 3Q | 81억 | 16억 | 15억 | 20.3% |
| 2025 4Q | 87억 | 16억 | 16억 | 18.6% |
| 2026 1Q | 81억 | 13억 | 11억 | 16.7% |
Company
Address: 경기도 성남시 분당구 판교로 253 C동 403호
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 비씨월드제약 | 324억 | — | 0.43 | -0.16% |
| 제놀루션 | 269억 | — | 0.37 | +3.62% |
| 고려제약 | 353억 | 5.33 | 0.42 | -8.29% |
| 샤페론 | 252억 | — | 1.02 | +6.67% |
| 유틸렉스 | 353억 | — | 2.31 | +0.00% |
| 에이프로젠바이오로직스 | 250억 | — | 0.10 | -10.83% |
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-06-29[기재정정]사업보고서 (2025.12)
- 2026-06-29[기재정정]사업보고서 (2025.12)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.